First Interstate Bank’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-241
Closed -$72K 195
2019
Q4
$72K Sell
241
-443
-65% -$123K 0.02% 246
2019
Q3
$159K Sell
684
-161
-19% -$37.5K 0.04% 195
2019
Q2
$197K Sell
845
-138
-14% -$31.9K 0.04% 180
2019
Q1
$232K Buy
983
+147
+18% +$46.3K 0.05% 166
2018
Q4
$252K Hold
836
0.06% 147
2018
Q3
$295K Sell
836
-49
-6% -$16.9K 0.06% 148
2018
Q2
$257K Buy
885
+468
+112% +$132K 0.06% 160
2018
Q1
$114K Sell
417
-10
-2% -$3.1K 0.03% 259
2017
Q4
$136K Sell
427
-233
-35% -$74.7K 0.03% 224
2017
Q3
$207K Sell
660
-427
-39% -$126K 0.04% 181
2017
Q2
$295K Buy
1,087
+200
+23% +$52.9K 0.06% 147
2017
Q1
$243K Buy
887
+500
+129% +$141K 0.05% 155
2016
Q4
$110K Hold
387
0.02% 254
2016
Q3
$121K Buy
387
+8
+2% +$2.37K 0.02% 248
2016
Q2
$92K Hold
379
0.02% 271
2016
Q1
$99K Hold
379
0.02% 263
2015
Q4
$116K Sell
379
-811
-68% -$233K 0.02% 257
2015
Q3
$347K Buy
+1,190
New +$393K 0.07% 143

Other funds holding BIIB

First Interstate Bank's BIIB Position: Q1 2020 in Review

First Interstate Bank sold out of Biogen (BIIB) in Q1 2020, closing a stake of 241 shares — an estimated $72K sold.

First Interstate Bank first reported a position in BIIB in Q3 2015 and held it in 18 quarters. The position peaked at $347K in Q3 2015. 1,098 funds tracked by Wall St. Rank hold BIIB as of Q1 2020.

  • First Interstate Bank reported no remaining Biogen position as of Q1 2020 after selling out during the quarter.
  • First Interstate Bank sold 241 Biogen shares in Q1 2020, an estimated $72K.
  • First Interstate Bank first reported a position in Biogen in Q3 2015 and held it in 18 quarters.
  • First Interstate Bank's Biogen position peaked at $347K in Q3 2015.
  • 1,098 funds tracked by Wall St. Rank held Biogen as of Q1 2020.

Based on First Interstate Bank's 13F filing for Q1 2020, filed 11 May 2020.